NeurixaHealthAI logo
HomeInvestors
Investor Relations

Production-Ready.
Plug In Anywhere.
Built for Scale.

NeurixaHealthAI™ is a live, deployed, revenue-generating platform — not a prototype. We're actively seeking investors, strategic partners, venturists, and capitalists to accelerate our global expansion across 47 countries.

$4M+ ARRProduction Ready47 CountriesPlug & PlayZero Rip-and-Replace

$4M+ Recurring Revenue · 200+ Healthcare Organizations · 47 Countries

$4M+
ARR
Recurring Revenue & Growing
200+
Healthcare Organizations
Health systems, payers, ACOs
94%
Net Revenue Retention
Best-in-class expansion
47
Countries Reached
Global plug-and-play deployments
90s
Avg. Prior Auth Decision
vs. 3–5 days industry average
$2.1B
Claims Processed
Trailing 12 months

Investment Thesis

Why NeurixaHealthAI™ Wins

Six structural advantages that compound over time — creating a defensible market position in the largest industry in the world.

Platform, Not Point Solution

Healthcare AI is fragmented — dozens of point solutions that don't talk to each other. NeurixaHealthAI™ is the operating system layer that unifies them. One platform, one data model, one contract.

Structural Cost Tailwinds

US healthcare spends $1T+ annually on administrative waste. CMS-0057-F, value-based care mandates, and payer pressure are forcing digitization — creating a non-discretionary demand cycle.

Regulatory Moat

HIPAA, HITRUST, SOC 2 Type II, and CMS-0057-F compliance takes 18–24 months to achieve. We've done it. New entrants face a compliance barrier that compounds with every new regulation.

Network Effects at Scale

Every new health system, payer, and EHR integration makes the platform more valuable for all participants. Payer-provider data loops improve AI accuracy — creating a compounding intelligence advantage.

AI-Native Architecture

Built AI-first from day one — not retrofitted onto legacy infrastructure. Our proprietary clinical language models are trained on 2.4B+ healthcare events, creating a data moat that widens with every deployment.

International Expansion Path

The administrative complexity problem exists in every developed healthcare market. Our FHIR-native architecture and modular compliance framework enables rapid international expansion from a proven US base.

Market Opportunity

$124B Total Addressable Market

Five high-growth segments, each with independent regulatory tailwinds and measurable ROI — all addressable from a single platform deployment.

$124B
Total Addressable Market
US healthcare AI, 2026
$38B
Serviceable Addressable Market
Platform-addressable today
$4.2B
Serviceable Obtainable Market
5-year target at current trajectory

Prior Authorization & RCM

Administrative automation across payer and provider workflows — the largest near-term opportunity.

$48B
14.2% CAGR

Population Health & Value-Based Care

Risk stratification, care gap closure, and SDOH integration for ACOs and payers.

$31B
18.7% CAGR

Smart Hospital Operations

Capacity management, discharge AI, and clinical workflow optimization.

$22B
16.1% CAGR

Emergency Medical Services

Dispatch optimization, en-route intelligence, and PCR automation.

$9B
21.4% CAGR

Pharmacy & PBM Optimization

Formulary AI, PBM transparency, and specialty drug management.

$14B
12.8% CAGR

Competitive Moat

Defensibility That Compounds.

NeurixaHealthAI™ benefits from six interlocking moats — each one reinforcing the others. The longer a health system is on the platform, the harder it is to replace, and the more valuable the network becomes for every participant.

Proprietary clinical LLMs trained on 2.4B+ events
HIPAA + HITRUST + SOC 2 Type II certified
CMS-0057-F compliant prior auth APIs
200+ pre-built EHR and payer integrations
Multi-year enterprise contracts (avg. 3.2 years)
Payer-provider data network with 340+ nodes

Unit Economics

Average Contract Value
Enterprise ACV, 3.2yr avg. term
$1.4M
Gross Margin
Software-like margins at scale
78%
Net Revenue Retention
Expansion from upsell + modules
94%
CAC Payback Period
Improving with brand momentum
18 months
LTV / CAC Ratio
Best-in-class for enterprise SaaS
8.4x
Rule of 40 Score
Growth rate + EBITDA margin
71

Use of Proceeds

How We Deploy Capital

Series C proceeds are allocated to accelerate the three highest-ROI growth levers — AI model development, enterprise sales, and infrastructure.

R&D & AI Model Development40%
Sales & Market Expansion30%
Infrastructure & Compliance18%
G&A & Operations12%

Leadership

Meet the Team

Healthcare AI experts, clinicians, and operators building the future.

🏥

Raj P.

Co-Founder | Architect of NeurixaHealthAI™

A seasoned enterprise architect with 20+ years of experience, Raj is the visionary behind NeurixaHealthAI™ — building a new operating layer for healthcare that transforms inefficiency into real-time revenue and intelligent care delivery.

LinkedIn
🤝

Anthony P.

Co-Founder & Enterprise Architect

20+ years enterprise systems experience. Leads strategic partnerships and product adoption across healthcare & enterprise.

LinkedIn
🧬

Venkat M.

Board Member & Biotech Expert

Global entrepreneur and advisor dedicated to AI-driven solutions that transform rural & underserved communities.

LinkedIn
☁️

Naveen N.

Cloud Architect

10+ years leading mission-critical cloud systems. Expert in operational excellence, automation, & secure enterprise architectures.

LinkedIn
👩‍⚕️

Rebecca P.

Executive Assistant & Operations

Certified Clinical Medical Assistant with 5+ years in clinical care & public health. Expert in healthcare administration & regulatory frameworks.

LinkedIn

Expert Advisors

Special Thanks to Our Mentors & Experts

Global healthcare leaders guiding NeurixaHealthAI™'s impact.

👨‍⚕️

Dr. Prabhu Kumar Challagali

Convenor — Commonwealth Medical Association, LondonPresident — Indian Medical Association

Renowned physician with decades of community care. COVID-19 response leader (4,000+ patients treated). HIV/AIDS research pioneer. Multiple prestigious honors.

🏥

Dr. Sugunakar Raju

Hospital Superintendent — COOLimca Book of World Records Holder

33+ years healthcare experience across rural & urban settings. High-risk maternal care specialist. Two Limca World Records for surgical excellence.

Global Research & Clinical Collaborators

Built With the World's Healthcare Experts

NeurixaHealthAI™ was developed through extensive collaboration with healthcare experts across multiple regions and specialties. We conducted comprehensive research across Australia, India, Canada, and the United Kingdom to build an adaptable, globally-aware solution.

Cardiology

Dr. R. SrinivasDr. Hareesh P.

Orthopedic Surgery

Dr. Sudheer Kumar Professor

Neurology

Dr. Joel M.Dr. Prabhu E.

Gynecology

Dr. Sudeepti

General Medicine

Dr. Joshnna Professor

Nursing & Care

Angelina T. — RNRebecca — Prime Health

“We are deeply grateful to the many administrators, clinicians, and healthcare professionals who shared their insights, challenges, and expertise to help shape NeurixaHealthAI™ into a truly global healthcare solution.”

— The NeurixaHealthAI™ Founding Team

Seeking World-Class Capital Partners

We're Looking for Investors
Who Take This to the Next Level.

NeurixaHealthAI™ is production-ready, revenue-generating, and deployed across 47 countries. We're not looking for believers — we're looking for world-class investors, venturists, and capitalists who recognize a category-defining platform and want to scale it globally.

$4M+ ARR. Plug-and-play. Zero rip-and-replace. The infrastructure is built. The revenue is real. The opportunity is now.

Growth Capital

Investors ready to accelerate global expansion — scaling our $4M+ ARR platform into a dominant market position across 47+ countries and new verticals.

Strategic Partners & Venturists

Healthcare systems, payer networks, and venture builders who bring distribution, relationships, and domain expertise alongside capital.

Institutional Capitalists

Funds and family offices seeking a proven, recurring-revenue healthcare AI platform with a clear path to category leadership and global scale.

Why Now · Why NeurixaHealthAI™

$4M+
Annual Recurring Revenue
Live & growing
47
Countries
Plug-and-play deployed
200+
Organizations
Health systems & payers
$124B
Total Addressable Market
Healthcare AI & admin

Access the Investor Data Room

Qualified investors can request access to our full data room — including audited financials, cohort analysis, customer references, and Series C term sheet.

This page contains forward-looking statements. Past performance does not guarantee future results. For accredited investors only.